Treatment of ZnPP, a HO-1 inhibitor, suppressed HIF-1α expression and VEGF production, accompanied by the enhanced proliferation of HCT-15 cells, suggesting that the angiogenesis for tumor growth is mediated by HIF-1α and VEGF [103]. This evidence concerns the gene HMOX1 and neoplasm.